SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-032354
Filing Date
2019-02-08
Accepted
2019-02-08 16:49:30
Documents
2
Group Members
ONYX PHARMACEUTICALS, INC.ONYX THERAPEUTICS, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d702271dsc13g.htm SC 13G 62816
2 EX-99.1 d702271dex991.htm EX-99.1 5294
  Complete submission text file 0001193125-19-032354.txt   69838
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Subject) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90539 | Film No.: 19580619
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences